8-KRegulation FDExhibits & Filings

TransDigm Group INC 8-K Report, Regulation FD Disclosure (Aug 7, 2019)

Filed August 7, 2019For Securities:TDG

Summary

TransDigm Group (TDG) announced on August 6, 2019, that it has entered into a definitive agreement to sell its Esterline Interface Technology (EIT) group of businesses to an affiliate of KPS Capital Partners, LP for approximately $190 million. This divestiture follows TransDigm's acquisition of Esterline Technologies Corporation earlier in March 2019, indicating a swift strategic decision to offload a segment of the acquired entity. The sale is anticipated to close in the first quarter of fiscal year 2020, subject to regulatory approvals and customary closing conditions. This transaction represents a strategic move by TransDigm to potentially streamline its portfolio and focus on core operations after a significant acquisition. Investors should monitor the progress of this sale, as its completion and the use of the proceeds could impact future financial performance and capital allocation decisions. The company has highlighted potential risks and uncertainties related to the closing of this EIT sale, including regulatory hurdles and the satisfaction of closing conditions.

Key Highlights

  • 1TransDigm Group has agreed to sell its Esterline Interface Technology (EIT) business.
  • 2The buyer is an affiliate of KPS Capital Partners, LP.
  • 3The sale price is approximately $190 million.
  • 4EIT was part of the Esterline Technologies Corporation acquisition completed in March 2019.
  • 5The transaction is expected to close in the first quarter of fiscal year 2020.
  • 6Completion is subject to regulatory approvals and customary closing conditions.

Frequently Asked Questions

TransDigm acquired Esterline in March 2019 and the decision to sell EIT shortly thereafter suggests a strategic review of the acquired assets. This could be to divest non-core businesses, optimize the portfolio, or realize value quickly from specific segments.

The sale is for approximately $190 million. While the exact financial impact is not detailed in this 8-K, investors should consider how this cash inflow might be used, such as debt reduction, share repurchases, or reinvestment in other areas of the business. The profit or loss on sale will also affect reported earnings.

Yes, TransDigm has indicated that risks include the ability to successfully complete the sale, satisfy various closing conditions, and obtain required regulatory approvals. Delays or failure to close could impact the company's strategic plans and financial outlook.

Forward-looking statements are statements about future events or expectations, such as the expected completion date of the sale, that are not historical facts. These statements are subject to risks and uncertainties that could cause actual results to differ materially from what is projected.